Fabrication, Optimization, and Evaluation of Paclitaxel and Curcumin Coloaded PLGA Nanoparticles for Improved Antitumor Activity

Haiyang Hu, Zuyue Liao, Mengyao Xu, Shengli Wan, Yuesong Wu, Wenjun Zou, Jianming Wu, Qingze Fan

ACS Omega · 2022 · 35 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

values to 4T1 and MCF-7 breast cancer cell lines compared to free drugs. In summary, BBD optimization of CUR and PTX coloaded nanoparticles yielded a favorable drug carrier that holds potential as an alternative treatment for anticancer therapy.

References

30